Patents by Inventor Bernard McGee

Bernard McGee has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7880878
    Abstract: The Nebulized Airborne Biohazard Stage Alert (NABSA) is a method utilizing an optical particle counter in conjunction with a fluorometer as triggers to detect and assess potential biohazard threats infused into surrounding air. In the first stage an optical particle counter is constantly passing sampled air in front of an energy source, in turn scattering light. This scattered light is evaluated to establish if the particles are above one micrometer in concentrations, and thus potentially an aerosolized threat. Such detection triggers the secondary stage in which the sample particles are tested for viability via processing through a dye with fluorescent properties affected when bonded with an entity universally found in all biological substances and a UV light source. The detection of concentrations of oversized, viable particles triggers the third stage to compare a sample of the particles to known biowarfare agents to delineate the specific agent species.
    Type: Grant
    Filed: June 14, 2010
    Date of Patent: February 1, 2011
    Assignee: Respiratory Management Technology
    Inventors: Michael McCawley, Simon Goetze, Phillip Green, II, Jeannette Hoy, Bernard McGee
  • Patent number: 7738100
    Abstract: The Nebulized Airborne Biohazard Stage Alert (NABSA) is a method utilizing an optical particle counter in conjunction with a fluorometer as triggers to detect and assess potential biohazard threats infused into surrounding air. In the first stage an optical particle counter is constantly passing sampled air in front of an energy source, in turn scattering light. This scattered light is evaluated to establish if the particles are above one micrometer in concentrations, and thus potentially an aerosolized threat. Such detection triggers the secondary stage in which the sample particles are tested for viability via processing through a dye with fluorescent properties affected when bonded with an entity universally found in all biological substances and a UV light source. The detection of concentrations of oversized, viable particles triggers the third stage to compare a sample of the particles to known biowarfare agents to delineate the specific agent species.
    Type: Grant
    Filed: July 21, 2006
    Date of Patent: June 15, 2010
    Assignee: Respiratory Management Technology
    Inventors: Michael McCawley, Simon Goetze, Phillip Green, II, Jeannette Hoy, Bernard McGee
  • Publication number: 20060086891
    Abstract: A light scattering photometer signal-enhancement systems includes an adaptive sample and subtract circuit controlled by a computer or microcontroller (MCU). The MCU controls the gain of a programmable-gain amplifier (PGA) cascade that is used to amplify the raw photometer signal. In order to maintain the DC accuracy, the DC offset contained in the raw signal from the photometer is estimated by an algorithmic within the MCU and then subtracted from the raw signal before allowing it to be amplified by the PGA cascade. In addition to DC estimation and adaptive cancellation, the MCU applies a digital filtering scheme to compensate irrelevant frequency bands in the amplified signal and offers user determined averaging functions for additional signal conditioning. Moreover, hardware filters are used to prevent signal aliasing by the analog to digital converters (ADC) and a 60 Hz notch filter suppresses general electrical noise.
    Type: Application
    Filed: October 24, 2005
    Publication date: April 27, 2006
    Inventors: Tal Gottesman, Bernard McGee, Vikram Bose-Mullick